Barclays started coverage on shares of Tenet Healthcare (NYSE:THC) in a research report report published on Tuesday, MarketBeat.com reports. The brokerage issued an equal weight rating and a $35.00 target price on the stock.

THC has been the subject of several other reports. Zacks Investment Research cut shares of Tenet Healthcare from a buy rating to a hold rating in a research note on Monday, August 13th. JPMorgan Chase & Co. lifted their price target on shares of Tenet Healthcare from $22.00 to $28.00 and gave the company an underweight rating in a report on Friday, August 10th. SunTrust Banks reiterated a hold rating and issued a $27.00 price target on shares of Tenet Healthcare in a report on Tuesday, April 17th. ValuEngine lowered shares of Tenet Healthcare from a strong-buy rating to a buy rating in a report on Wednesday, June 27th. Finally, Mizuho reiterated a buy rating and issued a $35.00 price target on shares of Tenet Healthcare in a report on Wednesday, May 9th. Two analysts have rated the stock with a sell rating, ten have assigned a hold rating and seven have assigned a buy rating to the stock. Tenet Healthcare has an average rating of Hold and an average price target of $30.24.

THC stock opened at $33.99 on Tuesday. The company has a market capitalization of $3.31 billion, a price-to-earnings ratio of 41.96, a PEG ratio of 1.46 and a beta of 1.05. The company has a debt-to-equity ratio of 24.66, a current ratio of 1.08 and a quick ratio of 1.01. Tenet Healthcare has a one year low of $12.25 and a one year high of $39.74.

Tenet Healthcare (NYSE:THC) last released its earnings results on Monday, August 6th. The company reported $0.49 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $0.25 by $0.24. The firm had revenue of $4.51 billion during the quarter, compared to analysts’ expectations of $4.57 billion. Tenet Healthcare had a negative net margin of 2.51% and a positive return on equity of 38.91%. Tenet Healthcare’s revenue for the quarter was down 6.2% on a year-over-year basis. During the same period in the previous year, the company earned ($0.17) EPS. sell-side analysts expect that Tenet Healthcare will post 1.7 EPS for the current year.

Several institutional investors and hedge funds have recently made changes to their positions in THC. NumerixS Investment Technologies Inc acquired a new position in shares of Tenet Healthcare during the 2nd quarter valued at $166,000. Advisors Preferred LLC acquired a new position in shares of Tenet Healthcare during the 2nd quarter valued at $163,000. Assetmark Inc. lifted its holdings in shares of Tenet Healthcare by 45.8% during the 2nd quarter. Assetmark Inc. now owns 5,093 shares of the company’s stock valued at $171,000 after acquiring an additional 1,601 shares in the last quarter. Vident Investment Advisory LLC acquired a new position in shares of Tenet Healthcare during the 2nd quarter valued at $207,000. Finally, LMR Partners LLP acquired a new position in shares of Tenet Healthcare during the 2nd quarter valued at $234,000.

About Tenet Healthcare

Tenet Healthcare Corporation operates as a diversified healthcare services company. It operates in three segments: Hospital Operations and Other, Ambulatory Care, and Conifer. The company's general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies.

Featured Story: Google Finance

Analyst Recommendations for Tenet Healthcare (NYSE:THC)

Receive News & Ratings for Tenet Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tenet Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.